Key result
Review details oral anticoagulation strategies to reduce thromboembolic complications in atrial fibrillation.
Why the study?
The burden of AF has increased over the past 20 years and is associated with elevated risks of death, ischemic stroke, disability, and hospitalization, requiring strategies to minimize complications during oral anticoagulant therapy.
Answers are grounded in this paper and cite their sources.
Over the past 20 years, the burden of atrial fibrillation (AF) has increased. AF is associated with increased risk of death, ischemic stroke and disability, hospitalization rates, and reduced quality of life. Treatment for this pathology is based on the correction of risk factors, underlying disease and anticoagulant therapy. The review considers strategies to minimize the risk of complications during oral anticoagulant therapy.
No takes yet. Share an insight, caveat, or question.
Kudriavtseva et al. (2019) conducted a review in Atrial fibrillation. Oral anticoagulant therapy was evaluated. Oral anticoagulant therapy strategies are reviewed to minimize the risk of thromboembolic complications in patients with atrial fibrillation (no quantitative data reported).
Synapse has enriched 10 related papers. Consider them for comparative context: